[1] |
Wang J, Xu Y, Chen Z, et al. Liver immune profiling reveals pathogenesis and therapeutics for biliary atresia[J]. Cell, 2020, 183(7):1867-1883.
doi: 10.1016/j.cell.2020.10.048
pmid: 33248023
|
[2] |
Ortiz-Perez A, Donnelly B, Temple H, et al. Innate immunity and pathogenesis of biliary atresia[J]. Front Immunol, 2020, 11:329.
doi: 10.3389/fimmu.2020.00329
pmid: 32161597
|
[3] |
Xiao Y, Liu R, Li X, et al. Long noncoding RNA H19 contributes to cholangiocyte proliferation and cholestatic liver fibrosis in biliary atresia[J]. Hepatology, 2019, 70(5):1658-1673.
doi: 10.1002/hep.v70.5
|
[4] |
Zhou K, Xie G, Wen J, et al. Histamine is correlated with liver fibrosis in biliary atresia[J]. Dig Liver Dis, 2016, 48(8):921-926.
doi: 10.1016/j.dld.2016.05.001
|
[5] |
Okubo R, Nio M, Sasaki H, et al. Impacts of early kasai portoenterostomy on short-term and long-term outcomes of biliary atresia[J]. Hepatol Commun, 2021, 5(2):234-243.
doi: 10.1002/hep4.v5.2
|
[6] |
Birtolo C, Pham H, Morvaridi S, et al. Cadherin-11 is a cell surface marker up-regulated in activated pancreatic stellate cells and is involved in pancreatic cancer cell migration[J]. Am J Pathol, 2017, 187(1):146-155.
doi: S0002-9440(16)30416-3
pmid: 27855278
|
[7] |
Chen X, Xiang H, Yu S, et al. Research progress in the role and mechanism of Cadherin-11 in different diseases[J]. J Cancer, 2021, 12(4):1190-1199.
doi: 10.7150/jca.52720
|
[8] |
Lodyga M, Cambridge E, Karvonen HM, et al. Cadherin-11-mediated adhesion of macrophages to myofibroblasts establishes a profibrotic niche of active TGF-β[J]. Sci Signal, 2019, 12(564):eaao3469.
doi: 10.1126/scisignal.aao3469
|
[9] |
Franzè E, Monteleone I, Laudisi F, et al. Cadherin-11 Is a Regulator of Intestinal Fibrosis[J]. J Crohns Colitis, 2020, 14(3):406-417.
doi: 10.1093/ecco-jcc/jjz147
|
[10] |
杨媛, 孙超, 高伟, 等. 胆道闭锁诊断及治疗指南(2018版)[J]. 临床肝胆病杂志, 2019, 35(11):2435-2440.
|
[11] |
中华医学会外科学分会胆道外科学组. 胆管扩张症诊断与治疗指南(2017版)[J]. 中华消化外科杂志, 2017, (16):767-774.
|
[12] |
Ishibashi H, Shimada M, Kamisawa T, et al. Japanese clinical practice guidelines for congenital biliary dilatation[J]. J Hepatobiliary Pancreat Sci, 2017, 24(1):1-16.
doi: 10.1002/jhbp.415
|
[13] |
Luo Y, Brigham D, Bednarek J, et al. Unique Cho-langiocyte-targeted IgM autoantibodies correlate with poor outcome in biliary atresia[J]. Hepatology, 2021, 73(5):1855-1867.
doi: 10.1002/hep.v73.5
|
[14] |
Schroer AK, Bersi MR, Clark CR, et al. Cadherin-11 blockade reduces inflammation-driven fibrotic remodeling and improves outcomes after myocardial infarction[J]. JCI Insight, 2019, 4(18):e131545.
doi: 10.1172/jci.insight.131545
|
[15] |
Kisseleva T, Brenner D. Molecular and cellular mecha-nisms of liver fibrosis and its regression[J]. Nat Rev Gastroenterol Hepatol, 2021, 18(3):151-166.
doi: 10.1038/s41575-020-00372-7
pmid: 33128017
|
[16] |
Dewidar B, Meyer C, Dooley S, et al. TGF-beta in hepatic stellate cell activation and liver fibrogenesis-updated 2019[J]. Cells, 2019, 8(11):1419.
doi: 10.3390/cells8111419
|
[17] |
Cao W, Song S, Fang G, et al. Cadherin-11 deficiency attenuates ang-II-induced atrial fibrosis and susceptibility to atrial fibrillation[J]. J Inflamm Res, 2021, 14:2897-2911.
doi: 10.2147/JIR.S306073
|
[18] |
Pedroza M, To S, Smith J, et al. Cadherin-11 contributes to liver fibrosis induced by carbon tetrachloride[J]. PLoS One, 2019, 14(7):e0218971.
doi: 10.1371/journal.pone.0218971
|
[19] |
周艳芬, 邬平, 李欣, 等. 血清GGT、DB在胆道闭锁和胆汁淤积症患儿中的水平变化及意义[J]. 山东医药, 2020, 60(31):15-18.
|